Desensitization, Immunologic

"Desensitization, Immunologic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Immunosuppression by the administration of increasing doses of antigen. Though the exact mechanism is not clear, the therapy results in an increase in serum levels of allergen-specific IMMUNOGLOBULIN G, suppression of specific IgE, and an increase in suppressor T-cell activity.

Descriptor ID	D003888
MeSH Number(s)	E02.095.465.425.450.310 E05.478.610.310
Concept/Terms	Desensitization, Immunologic Desensitization, Immunologic Immunologic Desensitization Desensitizations, Immunologic Immunologic Desensitizations Therapy, Hyposensitization Hyposensitization Therapies Therapies, Hyposensitization Hyposensitization Therapy Allergen Immunotherapy Allergen Immunotherapy Allergen Immunotherapies Immunotherapies, Allergen Immunotherapy, Allergen

Below are MeSH descriptors whose meaning is more general than "Desensitization, Immunologic".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Therapeutics [E02]
Biological Therapy [E02.095]
Immunomodulation [E02.095.465]
Immunotherapy [E02.095.465.425]
Immunosuppression [E02.095.465.425.450]
Desensitization, Immunologic [E02.095.465.425.450.310]
Investigative Techniques [E05]
Immunologic Techniques [E05.478]
Immunosuppression [E05.478.610]
Desensitization, Immunologic [E05.478.610.310]

Below are MeSH descriptors whose meaning is related to "Desensitization, Immunologic".

Below are MeSH descriptors whose meaning is more specific than "Desensitization, Immunologic".

Desensitization, Immunologic
Sublingual Immunotherapy

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Desensitization, Immunologic" by people in this website by year, and whether "Desensitization, Immunologic" was a major or minor topic of these publications.

Bar chart showing 10 publications over 8 distinct years, with a maximum of 2 publications in 2004 and 2022

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1995	1	0	1
1996	0	1	1
2004	2	0	2
2009	0	1	1
2016	1	0	1
2017	1	0	1
2020	0	1	1
2022	0	2	2

Below are the most recent publications written about "Desensitization, Immunologic" by people in Profiles.

Kaushik A, Dunham D, Han X, Do E, Andorf S, Gupta S, Fernandes A, Kost LE, Sindher SB, Yu W, Tsai M, Tibshirani R, Boyd SD, Desai M, Maecker HT, Galli SJ, Chinthrajah RS, DeKruyff RH, Manohar M, Nadeau KC. CD8+ T cell differentiation status correlates with the feasibility of sustained unresponsiveness following oral immunotherapy. Nat Commun. 2022 Nov 04; 13(1):6646.

View in: PubMed
Yepes-Nu?ez JJ, Guyatt GH, G?mez-Escobar LG, P?rez-Herrera LC, Chu AWL, Ceccaci R, Acosta-Madiedo AS, Wen A, Moreno-L?pez S, MacDonald M, Barrios M, Chu X, Islam N, Gao Y, Wong MM, Couban R, Garcia E, Chapman E, Oykhman P, Chen L, Winders T, Asiniwasis RN, Boguniewicz M, De Benedetto A, Ellison K, Frazier WT, Greenhawt M, Huynh J, Kim E, LeBovidge J, Lind ML, Lio P, Martin SA, O'Brien M, Ong PY, Silverberg JI, Spergel J, Wang J, Wheeler KE, Schneider L, Chu DK. Allergen immunotherapy for atopic dermatitis: Systematic review and meta-analysis of benefits and harms. J Allergy Clin Immunol. 2023 01; 151(1):147-158.

View in: PubMed
He Z, Vadali VG, Szabady RL, Zhang W, Norman JM, Roberts B, Tibshirani R, Desai M, Chinthrajah RS, Galli SJ, Andorf S, Nadeau KC. Increased diversity of gut microbiota during active oral immunotherapy in peanut-allergic adults. Allergy. 2021 03; 76(3):927-930.

View in: PubMed
Andorf S, Purington N, Block WM, Long AJ, Tupa D, Brittain E, Rudman Spergel A, Desai M, Galli SJ, Nadeau KC, Chinthrajah RS. Anti-IgE treatment with oral immunotherapy in multifood allergic participants: a double-blind, randomised, controlled trial. Lancet Gastroenterol Hepatol. 2018 02; 3(2):85-94.

View in: PubMed
Semancik E, Sayej WN. Oral immunotherapy for peanut allergy induces eosinophilic esophagitis: three pediatric case reports. Pediatr Allergy Immunol. 2016 08; 27(5):539-41.

View in: PubMed
Campbell JD, Buckland KF, McMillan SJ, Kearley J, Oldfield WL, Stern LJ, Gr?nlund H, van Hage M, Reynolds CJ, Boyton RJ, Cobbold SP, Kay AB, Altmann DM, Lloyd CM, Larch? M. Peptide immunotherapy in allergic asthma generates IL-10-dependent immunological tolerance associated with linked epitope suppression. J Exp Med. 2009 Jul 06; 206(7):1535-47.

View in: PubMed
Gammon D, Bhargava P, McCormick MJ. Hypersensitivity reactions to oxaliplatin and the application of a desensitization protocol. Oncologist. 2004; 9(5):546-9.

View in: PubMed
Bhargava P, Gammon D, McCormick MJ. Hypersensitivity and idiosyncratic reactions to oxaliplatin. Cancer. 2004 Jan 01; 100(1):211-2.

View in: PubMed
Brettler DB. Inhibitors in congenital haemophilia. Baillieres Clin Haematol. 1996 Jun; 9(2):319-29.

View in: PubMed
Tinkelman D, Smith F, Cole WQ, Silk HJ. Compliance with an allergen immunotherapy regime. Ann Allergy Asthma Immunol. 1995 Mar; 74(3):241-6.

View in: PubMed

People

Explore

Similar Concepts

Top Journals